Chao DT - Search Results

1

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR.

Purcell JW, Kim HK, Tanlimco SG, Doan M, Fox M, Lambert P, Chao DT, Sho M, Wilson KE, Starling GC, Culp PA. Purcell JW, et al. Among authors: chao dt. Front Immunol. 2014 Jan 8;4:505. doi: 10.3389/fimmu.2013.00505. eCollection 2014. Front Immunol. 2014. PMID: 24409185 Free PMC article.

2

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.

Chao DT, Su M, Tanlimco S, Sho M, Choi D, Fox M, Ye S, Hsi ED, Durkin L, Yin J, Zhang Y, Kim H, Starling GC, Culp PA. Chao DT, et al. J Cancer Res Clin Oncol. 2013 Feb;139(2):315-25. doi: 10.1007/s00432-012-1332-x. Epub 2012 Oct 17. J Cancer Res Clin Oncol. 2013. PMID: 23073510 Free PMC article.

3

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.

Ye S, Fox MI, Belmar NA, Sho M, Chao DT, Choi D, Fang Y, Zhao V, Keller SF, Starling GC, Culp PA. Ye S, et al. Among authors: chao dt. J Immunol Res. 2017;2017:5737159. doi: 10.1155/2017/5737159. Epub 2017 Sep 17. J Immunol Res. 2017. PMID: 29075649 Free PMC article.

4

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways.

Balasa B, Yun R, Belmar NA, Fox M, Chao DT, Robbins MD, Starling GC, Rice AG. Balasa B, et al. Among authors: chao dt. Cancer Immunol Immunother. 2015 Jan;64(1):61-73. doi: 10.1007/s00262-014-1610-3. Epub 2014 Oct 7. Cancer Immunol Immunother. 2015. PMID: 25287778 Free PMC article.

5

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates.

Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT. Purcell JW, et al. Among authors: chao dt. Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15. Cancer Res. 2018. PMID: 29764866

6

A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity.

Ye S, Cohen D, Belmar NA, Choi D, Tan SS, Sho M, Akamatsu Y, Kim H, Iyer R, Cabel J, Lake M, Song D, Harlan J, Zhang C, Fang Y, Wahl AF, Culp P, Hollenbaugh D, Chao DT. Ye S, et al. Among authors: chao dt. Cancer Immunol Res. 2019 Nov;7(11):1864-1875. doi: 10.1158/2326-6066.CIR-18-0805. Epub 2019 Aug 28. Cancer Immunol Res. 2019. PMID: 31462409

7

Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms.

Culp PA, Choi D, Zhang Y, Yin J, Seto P, Ybarra SE, Su M, Sho M, Steinle R, Wong MH, Evangelista F, Grove J, Cardenas M, James M, Hsi ED, Chao DT, Powers DB, Ramakrishnan V, Dubridge R. Culp PA, et al. Among authors: chao dt. Clin Cancer Res. 2010 Jan 15;16(2):497-508. doi: 10.1158/1078-0432.CCR-09-1929. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068083

8

Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity.

Ho SK, Xu Z, Thakur A, Fox M, Tan SS, DiGiammarino E, Zhou L, Sho M, Cairns B, Zhao V, Xiong M, Samayoa J, Forsyth CM, Powers DB, Chao DT, Hollenbaugh D, Alvarez HM, Akamatsu Y. Ho SK, et al. Among authors: chao dt. Mol Cancer Ther. 2020 Apr;19(4):1040-1051. doi: 10.1158/1535-7163.MCT-19-0608. Epub 2020 Jan 23. Mol Cancer Ther. 2020. PMID: 31974274

9

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.

Belmar NA, Lombardo JR, Chao DT, Li O, Ma X, Pong-Afar M, Law DA, Starling GC. Belmar NA, et al. Among authors: chao dt. J Neuroimmunol. 2009 Jul 25;212(1-2):65-73. doi: 10.1016/j.jneuroim.2009.04.022. Epub 2009 May 23. J Neuroimmunol. 2009. PMID: 19477024

10

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.

Woo J, Vierboom MP, Kwon H, Chao D, Ye S, Li J, Lin K, Tang I, Belmar NA, Hartman T, Breedveld E, Vexler V, 't Hart BA, Law DA, Starling GC. Woo J, et al. Arthritis Res Ther. 2013;15(6):R207. doi: 10.1186/ar4400. Arthritis Res Ther. 2013. PMID: 24299175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters